Cargando…
HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma
Human malignant mesothelioma (MM) is an aggressive cancer linked to asbestos and erionite exposure. We previously reported that High-Mobility Group Box-1 protein (HMGB1), a prototypic damage-associated molecular pattern, drives MM development and sustains MM progression. Moreover, we demonstrated th...
Autores principales: | Pellegrini, Laura, Xue, Jiaming, Larson, David, Pastorino, Sandra, Jube, Sandro, Forest, Kelly H., Saad-Jube, Zeyana Salim, Napolitano, Andrea, Pagano, Ian, Negi, Vishal S., Bianchi, Marco E., Morris, Paul, Pass, Harvey I., Gaudino, Giovanni, Carbone, Michele, Yang, Haining |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410252/ https://www.ncbi.nlm.nih.gov/pubmed/28186988 http://dx.doi.org/10.18632/oncotarget.15152 |
Ejemplares similares
-
Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression
por: Yang, H, et al.
Publicado: (2015) -
FTY720 inhibits mesothelioma growth in vitro and in a syngeneic mouse model
por: Szymiczek, Agata, et al.
Publicado: (2017) -
Asbestos-induced chronic inflammation in malignant pleural mesothelioma and related therapeutic approaches—a narrative review
por: Zolondick, Alicia A., et al.
Publicado: (2021) -
Preventive and therapeutic opportunities: targeting BAP1 and/or HMGB1 pathways to diminish the burden of mesothelioma
por: Carbone, Michele, et al.
Publicado: (2023) -
Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma
por: Carbone, Michele, et al.
Publicado: (2016)